BeyondSpring Inc.

BYSI ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › Cash Flow Statement
Annual Quarterly

Cash Flow Statement

Line Item Jun 2026 Mar 2026 Dec 2025 Sep 2025 Jun 2025 Mar 2025 Dec 2024 Sep 2024
Operating Activities
Net Income $-849.0K $-2.2M $-2.1M $-1.5M $-1.8M $4.5M $-1.7M $-2.1M
Depreciation & Amortization — — — — — — — —
Depreciation $19.0K $19.0K $-156.0K $81.0K $82.0K $80.0K $20.0K $83.0K
Amortization — — — — — — — —
Stock-Based Compensation $575.0K $461.0K $167.0K $166.0K $145.0K $244.0K $399.0K $827.0K
Net Cash from Operating Activities $-3.8M $-3.3M $-5.5M $-4.2M $-5.9M $-4.2M $982.0K $-5.2M
Investing Activities
Capital Expenditures $0 $0 $0 $0 $0 $50.0K $27.0K $197.0K
Business Acquisitions — — — — — — — —
Net Cash from Investing Activities $-5.0K $4.5M $-5.1M $-1.2M $10.9M $6.3M $-9.8M $-2.2M
Financing Activities
Dividends Paid — — — — — — — —
Stock Repurchases — — — — — — — —
Net Cash from Financing Activities $-74.0K $-4.2M $2.0M $3.0M $0 $0 — —
Net Change in Cash $-3.8M $-2.9M $-8.6M $-2.4M $5.0M $2.1M $-7.0M $14.7M
Free Cash Flow $-3.8M $-3.3M $-5.5M $-4.2M $-5.9M $-4.2M $955.0K $-5.4M
← Newer Page 1 of 2 Older →